QR Code

CLINICAL AND HEMODYNAMIC PROFILE AND NEUROHORMONAL INDICATORS IN PATIENTS WITH IDIOPATHIC PULMONARY HYPERTENSION, DEPENDING ON VASOREACTIVITY RESERVE OF PULMONARY ARTERIES

Clinical and hemodynamic profile and neurohormonal indicators in patients with idiopathic pulmonary hypertension, depending on vasoreactivity reserve of pulmonary arteries. Objective: the main objective of our research work was an evaluation of clinical and hemodynamic profile, neurohormonal indicat...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. M. Paramonov, T. V. Martynyuk, Z. H. Dadacheva, N. M. Danilov, V. P. Masenko, I. Ye. Chazova
Format:	Article
Language:	Russian
Published:	InterMedservice 2016-03-01
Series:	Евразийский Кардиологический Журнал
Subjects:	идиопатическая лёгочная гипертензия острая фармакологическая проба катетеризация правых отделов сердца нейрогуморальные показатели idiopathic pulmonary hypertension acute pharmacological testing right heart catheterization neurohormonal indicators
Online Access:	https://www.heartj.asia/jour/article/view/5658
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

THE RESULTS OF LONG-TERM PAH-SPECIFIC MONOTHERAPY WITH BOSENTAN IN PATIENTS WITH IDIOPATHIC PULMONARY HYPERTENSION
by: V. M. Paramonov, et al.
Published: (2016-06-01)

FEATURES OF CUTANEOUS MICROCIRCULATORY BLOOD FLOW IN PATIENTS WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION ASSESSED BY LASER DOPPLER FLOWMETRY DEPENDING ON VASOREACTIVITY STATUS ON INHALED NITRIC OXIDE
by: E. V. Dolgova, et al.
Published: (2016-06-01)

CLINICAL CASE: THERAPY WITH SILDENAFIL IN THE TREATMENT OF IDIOPATHIC PULMONARY HYPERTENSION
by: Z. S. Valieva, et al.
Published: (2015-12-01)

CLINICAL CASE OF SUCCESSFUL 10-YEAR AMBRIZENTAN TREATMENT OF THE PATIENT WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION
by: T. V. Martynyuk, et al.
Published: (2015-12-01)

APPLICATION OF PHOSPHODIESTERASE TYPE 5 INHIBITORS SILDENAFIL IN PATIENTS WITH PULMONARY HYPERTENSION
by: T. V. Martynyuk, et al.
Published: (2015-06-01)

SUCCESSFUL TREATMENT OF INOPERABLE THROMBOEMBOLIC PULMONARY HYPERTENSION PATIENT WITH SILDENAFIL IN HIGH DOSES
by: Z. H. Dadacheva, et al.
Published: (2014-12-01)

PULMONAR.Y ARTERIAL HYPERTENSION ASSOCIATED WITH A SYSTEMIC SCLEROSIS: REVIEW OF LITERATURE
by: N. N. Yudkina, et al.
Published: (2015-12-01)

CLINICAL CASE: COMBINATION THERAPY WITH BOSENTAN AND SILDENAFIL IN THE TREATMENT OF IDIOPATHIC PULMONARY HYPERTENSION
by: V. V. Bystrov, et al.
Published: (2014-12-01)

FEATURES OF PULMONARY ARTERIAL HYPERTENSION IN THE RUSSIAN REGISTER
by: O. A. Arkhipova, et al.
Published: (2014-12-01)

THE DIAGNOSIS AND TREATMENT OF PRIMARY PULMONARY HYPERTENSION: A MODERN VIEW ON THE PROBLEM
by: N. V. Porodenko, et al.
Published: (2014-06-01)

Pulmonary hypertension: current issues of diagnosis and treatment
by: T. V. Martyniuk, et al.
Published: (2011-03-01)

PERFUSION LUNG SCINTIGRAPHY IN PATIENTS WITH A PULMONARY HYPERTENSION OF A VARIOUS ETIOLOGY
by: O. A. Arkhipova, et al.
Published: (2015-12-01)

MACITENTAN: THE EVOLUTION OF THE CLASS ENDOTHELIN RECEPTOR ANTAGONISTS TO IMPROVE EFFICACY AND SAFETY OF PAH TREATMENT
by: T. V. Martynuk, et al.
Published: (2013-06-01)

AMBRISENTAN: THE POSSIBILITY OF THE TREATMENT FOR PULMONARY ARTERIAL HYPERTENSION WITH THE SELECTIVE BLOCKADE OF THE ENDOTHELIN SYSTEM
by: T. V. Martynuk, et al.
Published: (2014-03-01)

INFLUENCE EVALUATION OF LONG-TERM THERAPY WITH EKVATOR® AND PREDISIN® ON MORPHOFUNCTIONAL RATES AND PAINLESS MYOCARDIAL ISCHEMIA IN PREMENOPAUSAL WOMEN WITH HYPOESTROGENEMIA AND HYPERTENSION
by: M. M. Habibulina
Published: (2014-12-01)

Refractory Arterial Hypertension: Features of Neurohormonal and Water-salt Imbalanceand Approaches to Antihypertensive Drug Therapy
by: O. B. Kuzmin, et al.
Published: (2022-09-01)

MEDICAL TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
by: K. V. Mershin, et al.
Published: (2014-03-01)

NEW OPPORTUNITIES PATHOGENETIC THERAPY OF PULMONARY ARTERIAL HYPERTENSION
by: T. V. Martynuk, et al.
Published: (2013-03-01)

SURGICAL TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: MODERN TRENDS AND OWN EXPERIENCE
by: R. S. Akchurin, et al.
Published: (2016-06-01)

Vasoreactivity testing in pulmonary hypertension associated with congenital heart disease
by: A. A. Shmalts, et al.
Published: (2022-10-01)

Pediatric Pulmonary Hypertension is Associated With Increased Circulating Levels of BMP 7 and CHIP
by: Edward C. Kirkpatrick, et al.
Published: (2025-04-01)

STRUCTURAL AND FUNCTIONAL CHANGES OF THE HEART IN COAL INDUSTRY WORKERS
by: Ольга Юрьевна Коротенко, et al.
Published: (2021-08-01)

Peculiarities of application of pulmonary rehabilitation program in patients with chronic obstructive pulmonary disease
by: Yu. G. Krylova, et al.
Published: (2015-12-01)

The first Russian experience with the endothelin 1 receptor inhibitor traclir used in patients with pulmonary hypertension associated with systemic connective tissue diseases
by: Aleksandr Vitalyevich Volkov, et al.
Published: (2011-12-01)

EPIDEMIOLOGICAL ASPECTS OF IDIOPATHIC DILATED CARDIOMYOPATHY
by: A. S. Sisakyan, et al.
Published: (2003-08-01)

Enhanced immune responses of gregarious larvae contribute to successful adult migration in the migratory oriental armyworm
by: Hailong Kong, et al.
Published: (2025-08-01)

INHIBITOR OF SYNTHESIS OF TUMOR NECROSIS FACTOR-Α, PENTOXIFYLLINE, IN COMBINED THERAPY OF THE CHRONIC HEART FAILURE
by: O. P. Dudarenko, et al.
Published: (2016-01-01)

Variants of myocardial perfusion at rest, and their clinical assessment in patients with arterial hypertension and coronary heart disease
by: A. I. Kuzin, et al.
Published: (2004-04-01)

THE ROLE OF N-TERMINAL PRO-C-TYPE NATRIURETIC PEPTIDE AS A DIAGNOSTIC BIOMARKER OF PULMONARY HYPERTENSION IN COPD PATIENTS
by: V. V. Gaynitdinova, et al.
Published: (2015-12-01)

Prevalence of the basic controllable risk factors for coronary heart disease in women living in the Republic of North Ossetia - Alania
by: A. Y. Datieva
Published: (2016-02-01)

PREOPERATIVE AND POSTOPERATIVE PULMONARY REHABILITATION IN PATIENTS WITH LUNG CANCER AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: S. Yu. Dobner, et al.
Published: (2020-03-01)

POSSIBILITIES FOR ECHOCARDIOGRAPHIC DETERMINATION OF PULMONARY ARTERY PRESSURE IN PATIENTS WITH SYSTEMIC CONNECTIVE TISSUE DISEASES: DATA OF A RHEUMATOLOGY EXPERT CENTER
by: E. V. Nikolaeva, et al.
Published: (2015-03-01)

Synaptic transmission molecules and their role in the pathogenesis of allergic rhinitis
by: A. V. Klimov, et al.
Published: (2022-01-01)

Modern recommendations on children’s baseline cardiopulmonary resuscitation (BLS 2010)
by: R.F. Tepaev, et al.
Published: (2012-10-01)

A Prospective Analysis of Vasoreactivity and Mortality in WHO Group 3 Pulmonary Hypertension
by: Daniel J. Strick, et al.
Published: (2025-04-01)

Medical tactical and operational-surgical soluition in infected pancreonecrosis
by: V. M. Bensman, et al.
Published: (2014-12-01)

DIFFERENTIAL DIAGNOSIS OF MYOCARDIAL ISCHEMIC INJURY IN CONDITIONS OF PERMANENT CARDIAC PACING
by: B. G. Iskenderov, et al.
Published: (2003-06-01)

The Heterogeneity of Pulmonary Hypertension Nomenclature in Empiric Research Studies: Systematic Findings From Three Western European Countries
by: Armella Santi, et al.
Published: (2025-04-01)

CHANGES IN SKIN MICROCIRCULATION ON THE ANTERIOR ABDOMINAL WALL OF PATIENTS WITH ACUTE SURGICAL PATHOLOGY
by: Кристина Валерьевна Валиахмедова, et al.
Published: (2019-02-01)

Circadian blood pressure profile in patients with arterial hypertension and chronic obstructive pulmonary disease
by: T. E. Steshina, et al.
Published: (2005-08-01)